OLI Technologies Inc.

Who Is Behind the Company

Thomas Weindl is the founder and CEO of OLI Technologies [Tracxn, LinkedIn]. Specific senior team data was not surfaced in the public research.

Data Accuracy: YELLOW -- Founding date and CEO confirmed by multiple directories; 2025 funding round corroborated by a regional I-Corps hub announcement. Operational milestones and detailed team background are not publicly verified.

Inside the Company

OLI Technologies Inc. was founded in April 2021 with the aim of decentralizing kidney care [Perplexity Sonar Pro]. The company is incorporated and operates from North Brunswick, New Jersey, in the United States [Tracxn]. Public records show Thomas Weindl as the founder and CEO [LinkedIn, Tracxn].

Initial development appears to have been supported by non-dilutive grant funding. In 2025, the company announced a $700,000 seed funding round led by the Verge HealthTech Fund [NSF I-Corps Hub Northeast Region, 2025].

Data Accuracy: YELLOW -- Founding date and CEO confirmed by multiple directories; 2025 funding round corroborated by a regional I-Corps hub announcement. Operational milestones and detailed team background are not publicly verified.

Under the Hood

OLI Technologies is developing a portable, compact hemodialysis device intended to move kidney care out of centralized clinics. The company's public positioning frames its technology as enabling "clinical-grade dialysis" in home and community settings [Perplexity Sonar Pro]. The core wedge is a low-cost, wearable system designed for end-stage kidney disease patients [Perplexity Sonar Pro, Tracxn].

Data Accuracy: YELLOW -- Product concept is described in directory listings and a company profile; technical specifications and regulatory progress are not publicly confirmed.

Market Research and Opportunity

The market for decentralized kidney care is being reshaped by a mismatch between patient need and the capacity of the traditional, clinic-based dialysis system. In the United States, over 800,000 people live with end-stage kidney disease (ESKD), with the majority receiving in-center hemodialysis treatment three times a week [National Institute of Diabetes and Digestive and Kidney Diseases, 2024].

Market Segment	Reported Size (2023)	Projected Size (2030)
Global Dialysis Market (Analogous)	~$105B	~$140B

Data Accuracy: YELLOW -- Market driver and regulatory context are well-documented by public health agencies. The $105B market size is cited from a third-party analyst report. The specific SAM for portable devices and OLI's internal projections are not publicly available.

Competition and Substitutes

OLI Technologies enters a medical device market defined by entrenched clinical incumbents and a small group of startups pursuing the same vision of portable dialysis.

Company	Positioning	Stage / Funding
OLI Technologies	Portable, compact hemodialysis for decentralized care.	Seed; $700k raised [Tracxn, NSF I-Corps Hub Northeast Region, 2025].
Quanta Dialysis Technologies	Developer of the SC+ hemodialysis system.	Later stage; raised ~$245 million total.
AWAK Technologies	Developer of a wearable, sorbent-based peritoneal dialysis (PD) device.	Venture-backed; raised ~$30 million total.

Data Accuracy: YELLOW -- Competitor profiles and funding are drawn from public databases but lack recent primary source verification for Quanta and AWAK. OLI's differentiation is sourced from its own positioning statements.

Opportunity

The potential outcome for OLI Technologies is a shift in the economics and accessibility of kidney care. If the company's technology proves viable and secures regulatory approval, it could capture a portion of the global dialysis market by enabling a more convenient, lower-cost treatment model.

Data Accuracy: YELLOW -- The opportunity analysis is based on the company's stated mission and industry trends, but specific catalysts and comparables are drawn from limited public sources.

Sources

1. [Tracxn] OLI Technologies - 2026 Company Profile, Team, Funding & Competitors - Tracxn | https://tracxn.com/d/companies/olitechnologies/__W9CxDS1u8Ik4gli2IUpl-Z6dqkSejkWqkbAfVA5vhHU
2. [LinkedIn] Thomas Weindl, MBA - founder @ oli | medtech / hardtech | LinkedIn | https://www.linkedin.com/in/tcweindl/
3. [NSF I-Corps Hub Northeast Region, 2025] OLI Technologies raises seed round funding led by Verge HealthTech Fund | NSF I-Corps Hub Northeast Region | https://icorpsnortheasthub.org/news/2025/oli-technologies-raises-seed-round-funding-led-verge-healthtech-fund
4. [National Institute of Diabetes and Digestive and Kidney Diseases, 2024] Kidney Disease Statistics for the United States | https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease
5. [CMS, 2021] ESRD Treatment Choices (ETC) Model | https://innovation.cms.gov/innovation-models/esrd-treatment-choices-model
6. [Grand View Research, 2024] Dialysis Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/dialysis-market
7. [United States Renal Data System, 2023] USRDS Annual Data Report | https://usrds-adr.niddk.nih.gov/
8. [Crunchbase] Quanta Dialysis Technologies - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/quanta-dialysis-technologies
9. [Crunchbase] AWAK Technologies - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/awak-dialysis-technologies